Intravenous erythromycin overcomes small intestinal feedback on antral, pyloric, and duodenal motility.
Gastroenterology. 1992 Jul;103(1):114-9. doi: 10.1016/0016-5085(92)91103-b.
Gastroenterology. 1992.
PMID: 1612319
Clinical Trial.